U.S. federal trademark · Serial No. 99501136 · Reg. No. 8351842
Medical services, namely, treating medical patients for cancer and autoimmune diseases through biologic and genomic therapies in the fields of reversing biological aging and treating cancer through telomeric attrition, epigenetic and regenerative therapeutics; Medical services, namely, treating medical patients for cancer and autoimmune diseases with biologic and genomic therapies that restore tissue function, enhance immune competence, and promote cell regeneration based on proprietary secretome formulations, encapsulated gene therapies, and cell-based delivery platforms; Medical services, namely, treating medical patients for cancer and autoimmune diseases With thymic based cell regeneration therapies, secretome-driven rejuvenation therapies, gene therapies, cryoblation and immunotherapy for medical purposes; None of the foregoing for use in the research and data analytics for population health, geneaology, virology, or epidemiology
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.